LINC01094 and breast cancer: LINC01094 had high expression in aggressive BC cells (MDA‐MB‐231 and MDA‐MB‐468), but low expression in the non‐tumorigenic human mammary epithelial cell line MCF‐10A (Figure S1D, Supporting information).